Publications

6445 items matching your search terms.

A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia

Mohamed, S. M. A.; Wohlmann, A.; Schofield, P.; Sia, K. C. S.; McCalmont, H.; Savvides, S. N.; Verstraete, K.; Kavallaris, M.; Christ, D.; Friedrich, K. H.; Bayat, N.; Lock, R. B.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES 190 :214-223, 2021 10.1016/j.ijbiomac.2021.08.194

Subcellular relocalization and nuclear redistribution of the RNA methyltransferases TRMT1 and TRMT1L upon neuronal activation

Jonkhout, N.; Cruciani, S.; Santos Vieira, H. G.; Tran, J.; Liu, H.; Liu, G.; Pickford, R.; Kaczorowski, D.; Franco, G. R.; Vauti, F.; Camacho, N.; Abedini, S. S.; Najmabadi, H.; Ribas de Pouplana, L.; Christ, D.; Schonrock, N.; Mattick, J. S.; Novoa, E. M.

RNA Biology :1-15, 2021 10.1080/15476286.2021.1881291

Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment

Jonker, P. K. C.; Turchini, J.; Kruijff, S.; Lin, J. F.; Gill, A. J.; Eade, T.; Aniss, A.; Clifton-Bligh, R.; Learoyd, D.; Robinson, B.; Tsang, V.; Glover, A.; Sidhu, S.; Sywak, M.

ANNALS OF SURGICAL ONCOLOGY 2021 10.1245/s10434-021-10146-3

ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)

Emmett, L.; Subramaniam, S.; Joshua, A. M.; Crumbaker, M.; Martin, A.; Zhang, A. Y.; Rana, N.; Langford, A.; Mitchell, J.; Yip, S.; Francis, R.; Hofman, M. S.; Sandhu, S.; Azad, A.; Gedye, C.; McJannett, M.; Stockler, M. R.; Davis, I. D.; Australian, New Zealand Urogenital Prostate Cancer Trials Group the Enza-p investigators

BJU International 2021 10.1111/bju.15491

Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling

Butow, P.; Muller, F.; Napier, C. E.; Bartley, N.; Ballinger, M. L.; Biesecker, B.; Juraskova, I.; Meiser, B.; Schlub, T. E.; Thomas, D. M.; Goldstein, D.; Best, M. C.; Members of the PiGeOn, Project

PSYCHO-ONCOLOGY 2021 10.1002/pon.5764

Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening

Fang, G.; Lu, H.; Rodriguez de la Fuente, L.; Law, A. M. K.; Lin, G.; Jin, D.; Gallego-Ortega, D.

Advanced Science :e2102418, 2021 10.1002/advs.202102418

The Sequencing Quality Control 2 study: establishing community standards for sequencing in precision medicine

Mercer, T. R.; Xu, J.; Mason, C. E.; Tong, W.; Consortium, Maqc Seqc

GENOME BIOLOGY 22 (1) :306, 2021 10.1186/s13059-021-02528-3

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer

Portman, N.; Chen, J.; Lim, E.

Frontiers in Oncology 11 :777867, 2021 10.3389/fonc.2021.777867

Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency

Yap, J. Y.; Moens, L.; Lin, M. W.; Kane, A.; Kelleher, A.; Toong, C.; Wu, K. H. C.; Sewell, W. A.; Phan, T. G.; Hollway, G. E.; Enthoven, K.; Gray, P. E.; Casas-Martin, J.; Wouters, C.; De Somer, L.; Hershfield, M.; Bucciol, G.; Delafontaine, S.; Ma, C. S.; Tangye, S. G.; Meyts, I.

JOURNAL OF CLINICAL IMMUNOLOGY 41 (8) :1915-1935, 2021 10.1007/s10875-021-01141-0

Return of individual research results from genomic research: A systematic review of stakeholder perspectives

Vears, D. F.; Minion, J. T.; Roberts, S. J.; Cummings, J.; Machirori, M.; Blell, M.; Budin-Ljosne, I.; Cowley, L.; Dyke, S. O. M.; Gaff, C.; Green, R.; Hall, A.; Johns, A. L.; Knoppers, B. M.; Mulrine, S.; Patch, C.; Winkler, E.; Murtagh, M. J.

PLoS One 16 (11) :e0258646, 2021 10.1371/journal.pone.0258646

Lack of neuropeptide FF signalling in mice leads to reduced repetitive behavior, altered drinking behavior, and fuel type selection

Zhang, L.; Koller, J.; Ip, C. K.; Gopalasingam, G.; Bajaj, N.; Lee, N. J.; Enriquez, R. F.; Herzog, H.

FASEB JOURNAL 35 (11) :e21980, 2021 10.1096/fj.202100703R

Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings

Jia, F. F.; Drew, A. P.; Nicholson, G. A.; Corbett, A.; Kumar, K. R.

Neuromuscul Disord 31 (11) :1101-1112, 2021 10.1016/j.nmd.2021.09.010

The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous

Chen, J. M.; Huang, Q. Y.; Zhao, Y. X.; Chen, W. H.; Lin, S.; Shi, Q. Y.

Frontiers in Immunology 12 :785717, 2021 10.3389/fimmu.2021.785717

Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions

Nain, Z.; Barman, S. K.; Sheam, M. M.; Syed, S. B.; Samad, A.; Quinn, J. M. W.; Karim, M. M.; Himel, M. K.; Roy, R. K.; Moni, M. A.; Biswas, S. K.

BRIEFINGS IN BIOINFORMATICS 22 (6) :bbab197, 2021 10.1093/bib/bbab197

Y1 receptors modulate taste-related behavioral responsiveness in male mice to prototypical gustatory stimuli

Malone, I. G.; Hunter, B. K.; Rossow, H. L.; Herzog, H.; Zolotukhin, S.; Munger, S. D.; Dotson, C. D.

HORMONES AND BEHAVIOR 136 :105056, 2021 10.1016/j.yhbeh.2021.105056

Germline PALB2 Variants and PARP Inhibitors in Endometrial Cancer

Cilento, M. A.; Poplawski, N. K.; Paramasivam, S.; Thomas, D. M.; Kichenadasse, G.

Journal of the National Comprehensive Cancer Network 19 (11) :1212-1217, 2021 10.6004/jnccn.2021.7067